Transporters and renal drug elimination.
暂无分享,去创建一个
[1] R. Burk,et al. Immunologic distribution of an organic anion transport protein in rat liver and kidney. , 1996, The American journal of physiology.
[2] M. Hediger,et al. Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.
[3] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[4] Balázs Sarkadi,et al. The role of multidrug transporters in drug availability, metabolism and toxicity. , 2003, Toxicology letters.
[5] V. Ganapathy,et al. Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain* , 1998, The Journal of Biological Chemistry.
[6] T. Cihlar,et al. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.
[7] M. Okuda,et al. Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney , 1998, FEBS letters.
[8] Y. Sugiyama,et al. Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver* , 1998, The Journal of Biological Chemistry.
[9] H. Daniel,et al. An update on renal peptide transporters. , 2003, American journal of physiology. Renal physiology.
[10] F. Lang,et al. Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1* , 1996, The Journal of Biological Chemistry.
[11] D. Miller,et al. Mechanisms mediating renal secretion of organic anions and cations. , 1993, Physiological reviews.
[12] V. Schuster,et al. Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. , 1999, American journal of physiology. Renal physiology.
[13] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. H. Sweet,et al. Expression Cloning and Characterization of ROAT1 , 1997, The Journal of Biological Chemistry.
[15] G. Rappold,et al. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.
[16] Y. Kanai,et al. Cloning and Characterization of a Novel Multispecific Organic Anion Transporter * , 1997 .
[17] J. Kim,et al. Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.
[18] F. Russel,et al. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. , 2002, Journal of the American Society of Nephrology : JASN.
[19] P. Jansen,et al. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. , 1994, Pharmacology & therapeutics.
[20] Y. Tanigawara,et al. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. , 1993, The Journal of pharmacology and experimental therapeutics.
[21] H. Takikawa,et al. ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.
[22] H. Endou,et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.
[23] M. Romero,et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter , 1994, Nature.
[24] J. Nezu,et al. Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2* , 1998, The Journal of Biological Chemistry.
[25] D. Keppler,et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2 , 1999, Hepatology.
[26] D. H. Sweet,et al. rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. , 1999, American journal of physiology. Renal physiology.
[27] P. Meier,et al. Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.
[28] J. Nezu,et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.
[29] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[30] P. Swaan,et al. Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. , 1995, Biochimica et biophysica acta.
[31] M. Lebwohl,et al. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Wijnholds,et al. Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells* , 2003, The Journal of Biological Chemistry.
[33] F. Lang,et al. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1 , 1996, FEBS letters.
[34] V. Schuster,et al. Identification and characterization of a prostaglandin transporter. , 1995, Science.
[35] Heinz Bönisch,et al. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.
[36] Y. Sugiyama,et al. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[37] A. Aguzzi,et al. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. , 2000, The Journal of pharmacology and experimental therapeutics.
[38] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[39] H. Kusuhara,et al. Reduced folate derivatives are endogenous substrates for cMOAT in rats. , 1998, The American journal of physiology.
[40] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Keppler,et al. The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.
[42] K. Giacomini,et al. Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.
[43] D. Miller,et al. Renal secretion of organic anions and cations. , 1996, Kidney international.
[44] M. Hediger,et al. Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. , 1995, Biochimica et biophysica acta.
[45] A. Enomoto,et al. Role of human organic anion transporter 4 in the transport of ochratoxin A. , 2002, Biochimica et biophysica acta.
[46] A. Wolkoff,et al. The modified dipeptide, enalapril, an angiotensin‐converting enzyme inhibitor, is transported by the rat liver organic anion transport protein , 1998, Hepatology.
[47] P. Meier,et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. , 1995, Gastroenterology.
[48] S. Takenoshita,et al. Immuno-localization of H+/peptide cotransporter in rat digestive tract. , 1996, Biochemical and biophysical research communications.
[49] J. A. Nelson,et al. A transfected cell model for the renal toxin transporter, rOCT2. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[50] H. Koepsell,et al. Molecular Pharmacology of Organic Cation Transporters in Kidney , 1999, The Journal of Membrane Biology.
[51] P. Meier,et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[52] M. Kool,et al. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport , 2000, British Journal of Cancer.
[53] A. Enomoto,et al. Interactions of human organic anion as well as cation transporters with indoxyl sulfate. , 2003, European journal of pharmacology.
[54] E. Holtzman,et al. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). , 1999, Biochemical and biophysical research communications.
[55] D. Keppler,et al. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin‐johnson syndrome , 2000, Hepatology.
[56] P. Meier,et al. Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. , 1996, The Journal of pharmacology and experimental therapeutics.
[57] G. Kruh,et al. Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein. , 1996, Biochemistry.
[58] N. Obermüller,et al. Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2* , 1998, The Journal of Biological Chemistry.
[59] V. Ganapathy,et al. β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.
[60] J. Wijnholds,et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. , 2003, Molecular pharmacology.
[61] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[62] H. Yawo,et al. Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2* , 1998, The Journal of Biological Chemistry.
[63] Y. Sugiyama,et al. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.
[64] Y. Tanigawara,et al. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). , 1992, The Journal of pharmacology and experimental therapeutics.
[65] A. Sekine,et al. Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in the Japanese population , 2002, Journal of Human Genetics.
[66] D. Keppler,et al. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. , 2000, Kidney international.
[67] V. Ganapathy,et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.
[68] A. Wolkoff,et al. Organic Anion Transporting Polypeptide Mediates Organic Anion/HCO3 − Exchange* , 1997, The Journal of Biological Chemistry.
[69] M. Breen,et al. pABC11 (Also Known as MOAT-C and MRP5), a Member of the ABC Family of Proteins, Has Anion Transporter Activity but Does Not Confer Multidrug Resistance When Overexpressed in Human Embryonic Kidney 293 Cells* , 1999, The Journal of Biological Chemistry.
[70] V. Ganapathy,et al. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. , 1998, Biochemical and biophysical research communications.
[71] R. Kim,et al. Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[72] Y. Kanai,et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.
[73] Y. Kanai,et al. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. , 2000, The Journal of pharmacology and experimental therapeutics.
[74] D. Keppler,et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. , 1997, The Biochemical journal.
[75] S. Yao,et al. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. , 1994, The Journal of biological chemistry.
[76] T. Cantz,et al. MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[77] H. Daniel,et al. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. , 1996, The Journal of pharmacology and experimental therapeutics.
[78] J. Beijnen,et al. Drug Interactions Between Antiretroviral Drugs and Comedicated Agents , 2003, Clinical pharmacokinetics.
[79] D. Keppler,et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.
[80] Maristela L Onozato,et al. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.
[81] H. Saito,et al. Characterization of stably transfected kidney epithelial cell line expressing rat H+/peptide cotransporter PEPT1: localization of PEPT1 and transport of beta-lactam antibiotics. , 1997, The Journal of pharmacology and experimental therapeutics.
[82] K. Hirsch‐Ernst,et al. Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. , 1995, Biochemical and biophysical research communications.
[83] D. Roden,et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.
[84] M. Namer,et al. CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN , 1986, The Lancet.
[85] A. Guo,et al. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. , 1998, Biochemical and biophysical research communications.
[86] F. Lang,et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.
[87] P. Meier,et al. Multispecific amphipathic substrate transport by an organic anion transporter of human liver. , 1996, Journal of hepatology.
[88] B. Sikic,et al. Pharmacological considerations in the modulation of multidrug resistance. , 1996, European journal of cancer.
[89] Conrad C. Huang,et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. , 2002, Pharmacogenetics.
[90] A. Enomoto,et al. Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.
[91] M. Takano,et al. H+ coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes. , 1986, The Journal of biological chemistry.
[92] M. Willingham,et al. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[93] P. Dawson,et al. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.
[94] D. Gründemann,et al. Catecholamine transport by the organic cation transporter type 1 (OCT1) , 1998, British journal of pharmacology.
[95] S. Masuda,et al. Cloning and Functional Characterization of a Novel Rat Organic Anion Transporter Mediating Basolateral Uptake of Methotrexate in the Kidney* , 1996, The Journal of Biological Chemistry.
[96] H. Endou,et al. The multispecific organic anion transporter (OAT) family , 2000, Pflügers Archiv.
[97] J. A. Nelson,et al. Role of organic cation transporters in the renal secretion of nucleosides. , 2000, Biochemical pharmacology.
[98] V. Schuster,et al. Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. , 1996, The American journal of physiology.
[99] M. Fromm,et al. Genetic polymorphisms of the human MDR1 drug transporter. , 2003, Annual review of pharmacology and toxicology.
[100] Y. Sugiyama,et al. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). , 1997, The Journal of pharmacology and experimental therapeutics.
[101] J. Nezu,et al. Studies on Functional Sites of Organic Cation/Carnitine Transporter OCTN2 (SLC22A5) Using a Ser467Cys Mutant Protein , 2002, Journal of Pharmacology and Experimental Therapeutics.
[102] K. Giacomini,et al. Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. , 2001, Journal of pharmaceutical sciences.
[103] H. Saito,et al. Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1. , 2000, European journal of pharmacology.
[104] K. Giacomini,et al. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. , 1999, The Journal of pharmacology and experimental therapeutics.
[105] A. Enomoto,et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.
[106] F. Baas,et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[107] K. Giacomini,et al. Functional and Molecular Characteristics of Na+-dependent Nucleoside Transporters , 1997, Pharmaceutical Research.
[108] H. Coley,et al. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[109] Hiroshi Suzuki,et al. Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)* , 1999, The Journal of Biological Chemistry.
[110] D. Miller,et al. Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. , 2000, American journal of physiology. Renal physiology.
[111] M. Gottesman,et al. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi‐drug transporter , 1993, International journal of cancer.
[112] R. Kim. MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. , 2002, Pharmacogenetics.
[113] F. Russel,et al. Mechanisms and clinical implications of renal drug excretion* , 2001, Drug metabolism reviews.
[114] Y. Sugiyama,et al. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[115] H. Endou,et al. Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. , 2001, European journal of pharmacology.
[116] V. Schuster,et al. Mechanism of Prostaglandin E2 Transport across the Plasma Membrane of HeLa Cells and Xenopus Oocytes Expressing the Prostaglandin Transporter “PGT”* , 1998, The Journal of Biological Chemistry.
[117] W. Hwu,et al. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients , 2002, Human mutation.
[118] K. Cundy. Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir , 1999, Clinical pharmacokinetics.
[119] S. Masuda,et al. Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1. , 1997, The Journal of pharmacology and experimental therapeutics.
[120] David E. Smith,et al. Competitive Inhibition of Glycylsarcosine Transport by Enalapril in Rabbit Renal Brush Border Membrane Vesicles: Interaction of ACE Inhibitors with High-Affinity H+/Peptide Symporter , 1999, Pharmaceutical Research.
[121] F. Baas,et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.
[122] Joseph W. Polli,et al. Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor , 1999, Pharmaceutical Research.
[123] M. Takano,et al. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. , 1996, Biochemical and biophysical research communications.
[124] T. Cihlar,et al. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.
[125] M. Takano,et al. Carrier-mediated transport of cephalexin via the dipeptide transport system in rat renal brush-border membrane vesicles. , 1984, Biochimica et biophysica acta.
[126] V. Ganapathy,et al. Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta* , 1998, The Journal of Biological Chemistry.
[127] V. Schuster,et al. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). , 1996, The Journal of clinical investigation.
[128] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .
[129] T. Visser,et al. Identification of thyroid hormone transporters. , 1999, Biochemical and biophysical research communications.
[130] R. Evers,et al. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione , 1999 .
[131] K. Giacomini,et al. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). , 1998, The Journal of pharmacology and experimental therapeutics.
[132] T. Cantz,et al. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B , 1998, Hepatology.
[133] H. Endou,et al. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[134] H. Koepsell,et al. Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.
[135] A. Takeuchi,et al. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. , 2001, Kidney international.
[136] A Takeuchi,et al. Multispecific substrate recognition of kidney-specific organic anion transporters OAT-K1 and OAT-K2. , 2001, The Journal of pharmacology and experimental therapeutics.
[137] Y. Kanai,et al. The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. , 1999, The Journal of pharmacology and experimental therapeutics.
[138] W. Pardridge,et al. Differential kinetics of transport of 2',3'-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood-brain barrier. , 2001, The Journal of pharmacology and experimental therapeutics.
[139] A. Takeuchi,et al. Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1. , 2000, The Journal of pharmacology and experimental therapeutics.
[140] G. Tsujimoto,et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter , 1999, Nature Genetics.
[141] H. Saito,et al. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2. , 1999, The Journal of pharmacology and experimental therapeutics.
[142] J. Beijnen,et al. Assessing Safety and Efficacy of Directed P-Glycoprotein Inhibition to Improve the Pharmacokinetic Properties of Saquinavir Coadministered with Ritonavir , 2003, Journal of Pharmacology and Experimental Therapeutics.
[143] G R Wilkinson,et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[144] M. Erion,et al. Isolation of a family of organic anion transporters from human liver and kidney. , 2001, Biochemical and biophysical research communications.
[145] P. Meier,et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3 , 2001, Pflügers Archiv.
[146] H. Koepsell,et al. Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.
[147] A. Somogyi,et al. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[148] T. Abe,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a , 2000 .
[149] S. Masuda,et al. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.
[150] C. Boyd,et al. Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter. , 1998, Biochimica et biophysica acta.
[151] U. Brinkmann,et al. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. , 2001, Pharmacogenomics.
[152] K. Ullrich. Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates , 1997, The Journal of Membrane Biology.
[153] V. Ganapathy,et al. Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 (*) , 1995, The Journal of Biological Chemistry.
[154] H. Saito,et al. Recognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. , 1997, American journal of physiology. Renal physiology.
[155] Y. Sugiyama,et al. Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. , 1998, The Journal of pharmacology and experimental therapeutics.
[156] V. Ganapathy,et al. Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. , 1997, Biochimica et biophysica acta.
[157] G R Wilkinson,et al. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[158] H. Saito,et al. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. , 1993, The American journal of physiology.
[159] F. Döring,et al. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. , 1998, The Journal of clinical investigation.
[160] V. Ganapathy,et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. , 2000, Biochimica et biophysica acta.
[161] Jos H Beijnen,et al. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs , 2002, AIDS.
[162] D. Keppler,et al. cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.
[163] V. Sasseville,et al. A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.
[164] D. Barlow,et al. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.
[165] A. Takeuchi,et al. Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. , 1999, Molecular pharmacology.
[166] H. Koepsell,et al. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. , 2000, American journal of physiology. Renal physiology.
[167] H. Kusuhara,et al. Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. , 2001, The Journal of pharmacology and experimental therapeutics.
[168] P. Meier,et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.
[169] N. Ballatori,et al. Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter* , 1998, The Journal of Biological Chemistry.
[170] Y. Tanigawara,et al. Simvastatin and lovastatin, but not pravastatin, interact with MDR1 , 2002, The Journal of pharmacy and pharmacology.
[171] M. Hediger,et al. Differential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2 , 2000, Pharmaceutical Research.
[172] T. Abe,et al. In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. , 2003, Molecular pharmacology.
[173] V. Ganapathy,et al. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. , 1998, Biochemical and biophysical research communications.
[174] B. Sarkadi,et al. Loss of ATP-dependent Transport Activity in Pseudoxanthoma Elasticum-associated Mutants of Human ABCC6 (MRP6)* , 2002, The Journal of Biological Chemistry.
[175] H. Koepsell,et al. The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. , 2000, Journal of the American Society of Nephrology : JASN.
[176] J. Nezu,et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. , 2000, Biochemical and biophysical research communications.
[177] M. Fromm,et al. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. , 2000, The Journal of pharmacology and experimental therapeutics.
[178] K. Kohno,et al. Mutations in the Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene, a Novel ABC Transporter, in Patients with Hyperbilirubinemia II/Dubin-Johnson Syndrome , 1998 .
[179] F. Russel,et al. Molecular aspects of renal anionic drug transport. , 2002, Annual review of physiology.
[180] G. Groothuis,et al. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.
[181] R. Kim. Transporters and xenobiotic disposition. , 2002, Toxicology.
[182] H. Kusuhara,et al. Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.
[183] Y. Asano,et al. P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. , 2001, Journal of the American Society of Nephrology : JASN.
[184] S. Masuda,et al. Cellular and molecular aspects of drug transport in the kidney. , 2000, Kidney international.
[185] D. Smith,et al. Noncompetitive inhibition of glycylsarcosine transport by quinapril in rabbit renal brush border membrane vesicles: effect on high-affinity peptide transporter. , 1998, The Journal of pharmacology and experimental therapeutics.
[186] F. Lang,et al. Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.
[187] David J. Buttler,et al. Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. , 2000, Biochemical and biophysical research communications.
[188] S. Yao,et al. Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). , 1997, The American journal of physiology.
[189] D. Keppler,et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.
[190] K. Giacomini,et al. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). , 2000, The Journal of pharmacology and experimental therapeutics.
[191] J. Nezu,et al. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.
[192] A. Schinkel,et al. BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123 , 1998, Pharmaceutical Research.
[193] J. Nezu,et al. Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1 , 1997, FEBS letters.
[194] K. Brouwer,et al. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. , 2000, The Journal of pharmacology and experimental therapeutics.
[195] V. Schuster,et al. Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. , 1996, The American journal of physiology.
[196] T. Futami,et al. Interaction of β-Lactam Antibiotics with H+/Peptide Cotransporters in Rat Renal Brush-Border Membranes , 1998 .
[197] U. Brinkmann,et al. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. , 2002, Pharmacogenetics.
[198] R. Hyde,et al. Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)* , 2001, The Journal of Biological Chemistry.
[199] D. Keppler,et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.
[200] J. Schuetz,et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.
[201] R. Evers,et al. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. , 2000, Molecular pharmacology.
[202] A. Bröer,et al. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. , 2000, American journal of physiology. Renal physiology.
[203] Y. Minemoto,et al. p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. , 2000, Biochemical and biophysical research communications.
[204] D. Keppler,et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. , 1997, Journal of the American Society of Nephrology : JASN.
[205] A. Klein-Szanto,et al. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. , 2000, Journal of the National Cancer Institute.
[206] E. Seidman,et al. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[207] Liyue Huang,et al. Adenosine triphosphate–dependent transport of estradiol‐17β(β‐d‐glucuronide) in membrane vesicles by MDR1 expressed in insect cells , 1998 .
[208] N. Longo,et al. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[209] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[210] Y. Kanai,et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.
[211] P. Borst,et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[212] T. Futami,et al. Effect of clarithromycin on renal excretion of digoxin: Interaction with P‐glycoprotein , 1998, Clinical pharmacology and therapeutics.
[213] Zhe-Sheng Chen,et al. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.
[214] K. Roberg,et al. Molecular cloning and characterization of a novel liver-specific transport protein. , 1994, Journal of cell science.
[215] M. Kool,et al. Mutations in ABCC6 cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[216] Wolfgang Sadee,et al. 5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter , 1998, Pharmaceutical Research.
[217] C. Cass,et al. Recent advances in the molecular biology of nucleoside transporters of mammalian cells , 1998 .
[218] V Ganapathy,et al. Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1. , 1998, Journal of pharmaceutical sciences.
[219] Y. Kanai,et al. Transport of ochratoxin A by renal multispecific organic anion transporter 1. , 1998, The Journal of pharmacology and experimental therapeutics.
[220] D. Gründemann,et al. Selective substrates for non-neuronal monoamine transporters. , 1999, Molecular pharmacology.
[221] H. Endou,et al. Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion Transporters , 2002, Journal of Pharmacology and Experimental Therapeutics.
[222] Hori Ryohei,et al. Transport of bestatin in rat renal brush-border membrane vesicles , 1993 .
[223] V. Ganapathy,et al. Mutations in Novel Organic Cation Transporter (OCTN2), an Organic Cation/Carnitine Transporter, with Differential Effects on the Organic Cation Transport Function and the Carnitine Transport Function* , 1999, The Journal of Biological Chemistry.
[224] P. Meier,et al. Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[225] L Landmann,et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.
[226] D. Keppler,et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[227] E. Takeda,et al. Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter Npt1. , 1998, The Journal of pharmacology and experimental therapeutics.
[228] D. Gründemann,et al. Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2) , 2003, Journal of Pharmacology and Experimental Therapeutics.
[229] J. Wijnholds,et al. MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.
[230] Y. Sugiyama,et al. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. , 1997, Cancer research.
[231] W. E. Mol,et al. Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes. , 1988, The Journal of pharmacology and experimental therapeutics.
[232] Tianxin Yang,et al. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. , 1999, American journal of physiology. Renal physiology.
[233] J. Mackey,et al. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. , 1998, Molecular membrane biology.
[234] Y. Kanai,et al. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, American journal of physiology. Renal physiology.
[235] M. Hediger,et al. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions. , 1998, The Journal of clinical investigation.
[236] V. Ganapathy,et al. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. , 2000, Journal of pharmaceutical sciences.
[237] D. Meijer,et al. A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. , 1992, Biochemical pharmacology.
[238] M. Kool,et al. Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.
[239] A. Takeuchi,et al. Functional analysis of rat renal organic anion transporter OAT‐K1: bidirectional methotrexate transport in apical membrane , 1999, FEBS letters.
[240] P. Bosma,et al. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.
[241] Y. Sugiyama,et al. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan. , 2000, Drug metabolism and disposition: the biological fate of chemicals.